Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis

Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Teleflex Incorporated
Teleflex Incorporated News
Jun 12, 2025 - globenewswire.com
New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients
Jun 11, 2025 - globenewswire.com
Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men's Health Month
May 22, 2025 - globenewswire.com
Teleflex Incorporated Announcement: If You Have Suffered Losses in Teleflex Incorporated (NYSE: TFX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
May 21, 2025 - accessnewswire.com
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Teleflex Incorporated Investors to Inquire About Securities Class Action Investigation - TFX
Teleflex Incorporated Quantitative Score

About Teleflex Incorporated
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
Teleflex Incorporated Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
Teleflex Incorporated Financials
Table Compare
Compare TFX metrics with: | |||
---|---|---|---|
Earnings & Growth | TFX | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | TFX | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | TFX | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | TFX | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Teleflex Incorporated Income
Teleflex Incorporated Balance Sheet
Teleflex Incorporated Cash Flow
Teleflex Incorporated Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
Metrics | Score |
---|---|
Discounted Cash Flows | Strong Buy |
Return on Equity | Neutral |
Return on Assets | Buy |
Debt/Equity Ratio | Sell |
Price/Earnings Ratio | Strong Sell |
Price/Book Ratio | Neutral |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Teleflex Incorporated Dividends
Yield (TTM) | Dividend (TTM) | |
---|---|---|
Infinity% | 1.3600 |
Payment Date | Dividend | Frequency |
---|---|---|
2025-06-16 | 0.34 | Quarterly |
2025-03-17 | 0.34 | Quarterly |
2024-12-16 | 0.34 | Quarterly |
2024-09-16 | 0.34 | Quarterly |
2024-06-14 | 0.34 | Quarterly |
Historical Market Cap
Shares Outstanding
Teleflex Incorporated Executives
Name | Role |
---|---|
Mr. Liam J. Kelly | Chairman, President & Chief Executive Officer |
Mr. Jay K. White | Corporate Vice President & President of Global Commercial |
Mr. Daniel V. Logue J.D. | Corporate Vice President, General Counsel & Secretary |
Mr. Cameron P. Hicks | Corporate Vice President & Chief Human Resources Officer |
Mr. John R. Deren | Executive Vice President & Chief Financial Officer |
Name | Role | Gender | Date of Birth | Pay |
---|---|---|---|---|
Mr. Liam J. Kelly | Chairman, President & Chief Executive Officer | Male | 1967 | 3.05M |
Mr. Jay K. White | Corporate Vice President & President of Global Commercial | Male | 1974 | 1.21M |
Mr. Daniel V. Logue J.D. | Corporate Vice President, General Counsel & Secretary | Male | 1974 | 841.94K |
Mr. Cameron P. Hicks | Corporate Vice President & Chief Human Resources Officer | Male | 1965 | 564.68K |
Mr. John R. Deren | Executive Vice President & Chief Financial Officer | Male | -- |
Teleflex Incorporated Insider Trades
Date | 9 May |
Name | Duncan Candace H |
Role | Director |
Transaction | Acquired |
Type | A-Award |
Shares | 1051 |
Date | 9 May |
Name | Duncan Candace H |
Role | Director |
Transaction | Acquired |
Type | A-Award |
Shares | 2226 |
Date | 9 May |
Name | HEINMILLER JOHN C |
Role | Director |
Transaction | Acquired |
Type | A-Award |
Shares | 1051 |
Date | 9 May |
Name | HEINMILLER JOHN C |
Role | Director |
Transaction | Acquired |
Type | A-Award |
Shares | 2226 |
Date | 9 May |
Name | Patil Neena M |
Role | Director |
Transaction | Acquired |
Type | A-Award |
Shares | 1051 |
Date | Name | Role | Transaction | Type | Shares |
---|---|---|---|---|---|
9 May | Duncan Candace H | Director | Acquired | A-Award | 1051 |
9 May | Duncan Candace H | Director | Acquired | A-Award | 2226 |
9 May | HEINMILLER JOHN C | Director | Acquired | A-Award | 1051 |
9 May | HEINMILLER JOHN C | Director | Acquired | A-Award | 2226 |
9 May | Patil Neena M | Director | Acquired | A-Award | 1051 |